Specialty code 183500000X · Sacramento, CA
NPI
1265817126
Since 2015
Specialty
Specialty code 183500000X
Code 183500000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1650 Response Rd
Sacramento, CA, 95815
Phone (916) 606-6442
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$225K
2,354 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Yen Nguyen prescribed most often to Medicare patients was Atorvastatin Calcium, with 335 prescriptions and refills. In total Yen Nguyen wrote 2,354 Medicare prescriptions that cost $225K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-23.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 335 | 1,084 | 121 | $4,025 |
| Glipizide Generic | 291 | 950 | 108 | $4,247 |
| Metformin Hcl Er Metformin Hcl | 288 | 949 | 110 | $2,908 |
| Metformin Hcl Generic | 167 | 533 | 62 | $2,105 |
| Jardiance Empagliflozin | 126 | 413 | 57 | $74K |
| Humulin N Insulin Nph Human Isophane | 114 | 335 | 45 | $19K |
| Veo Insulin Syringe Syringe-Needle,insulin,0.5 Ml | 106 | 337 | 46 | $3,034 |
| Amlodipine Besylate Generic | 87 | 272 | 31 | $1,150 |
| Insulin Glargine-Yfgn Generic | 78 | 224 | 37 | $12K |
| Ozempic Semaglutide | 69 | 71 | 13 | $51K |
| Losartan Potassium Generic | 65 | 216 | 26 | $950 |
| Humulin R Insulin Regular, Human | 64 | 200 | 24 | $13K |
| Lisinopril Generic | 61 | 203 | 25 | $762 |
| Glipizide Er Glipizide | 58 | 188 | 23 | $1,737 |
| Hydrochlorothiazide Generic | 45 | 150 | 16 | $525 |
Brand drugs: 537 claims; generic drugs: 1,650 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Yen Nguyen were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.